Security Snapshot

enGene Therapeutics Inc. - Common Shares (ENGN) Institutional Ownership

CUSIP: 29286X101

13F Institutional Holders and Ownership History from Q1 2026 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

42

Shares (Excl. Options)

35.11MFull value: 35,107,140 · shares · 30 Sep 2026

Price

$2.00

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,664,341
Value change
+$8,314,214
Number of holders
42
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
69,859,146
SEC-reported price per share
$1.56
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ENGN - enGene Therapeutics Inc. - Common Shares is tracked under CUSIP 29286X101.
  • 42 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 56 to 42 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $66.59MFull value: $66,590,987 · USD · 30 Jun 2026
    to
    $70.21MFull value: $70,214,330 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 42 institutions filings for Q3 2026.

Open SEC evidence

Security key

29286X101

13F reference period

Q3 2026

13F holders

42

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
ENGN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Invus Global Management, LLC 9.3% $12,012,791 6,256,662 Raymond Debbane 30 Jun 2026
PERCEPTIVE ADVISORS LLC 8.9% $9,699,244 6,217,464 Perceptive Advisors LLC 30 Sep 2026
EVENTIDE ASSET MANAGEMENT, LLC 5.1% $5,790,239 3,406,023 Eventide Asset Management, LLC 30 Sep 2026
Blue Owl Capital Holdings LP 0.76% $981,460 511,177 Blue Owl Capital Holdings LP 30 Jun 2026
As of 30 Sep 2026, 42 institutional investors reported holding
35.11MFull value: 35,107,140 · shares · 30 Sep 2026
shares of enGene Therapeutics Inc. - Common Shares (ENGN). This represents 50% of the company’s total
69.86MFull value: 69,859,146 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
50%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BML Capital Management, LLC 9.5% 6,669,908 7.2% $13,339,816
Siren, L.L.C. 9% 6,256,662 0.3% $12,513,324
ACORN CAPITAL ADVISORS, LLC 5.5% 3,811,782 2.1% $7,623,564
PERCEPTIVE ADVISORS LLC 5% 3,482,169 0.13% $6,964,338
EVENTIDE ASSET MANAGEMENT, LLC 4.9% 3,406,023 0.1% $6,812,046
Nextech Invest Ltd. 3.3% 2,324,943 0.21% $4,649,886
Vestal Point Capital, LP 2.4% 1,665,000 0.09% $3,330,000
TWO SIGMA INVESTMENTS, LP 1.8% 1,292,137 0% $2,584,274
RENAISSANCE TECHNOLOGIES LLC 1.6% 1,134,400 0% $2,268,800
Peapod Lane Capital LLC 1.5% 1,038,617 1.5% $2,077,234
SR ONE CAPITAL MANAGEMENT, LP 1.1% 747,750 0.13% $1,495,500
Aldebaran Capital, LLC 0.94% 657,319 0.95% $1,314,638
FLPUTNAM INVESTMENT MANAGEMENT CO 0.8% 556,121 0.01% $1,112,242
Kynam Capital Management, LP 0.66% 457,855 0.05% $915,710
Rangeley Capital, LLC 0.41% 287,898 0.79% $575,796
Privium Fund Management B.V. 0.24% 170,000 0.07% $340,000
GSA CAPITAL PARTNERS LLP 0.18% 127,975 0.02% $256,000
XTX Topco Ltd 0.17% 117,582 0% $235,164
Quadrature Capital Ltd 0.14% 100,069 0% $200,138
Point72 Asset Management, L.P. 0.11% 75,552 0% $151,104
DAFNA Capital Management LLC 0.11% 74,650 0.03% $149,300
Carlson Capital, L.P. 0.07% 50,000 0.02% $100,000
AXQ CAPITAL, LP 0.07% 49,869 0.01% $99,738
PFS Partners, LLC 0.06% 40,000 0.03% $80,000
Engineers Gate Manager LP 0.06% 39,522 0% $79,044

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
3
Headline period
Q3 2026
Rows shown
1-3 of 3
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 35,107,140 $70,214,330 +$8,314,214 $2.00 42
2026 Q2 38,491,618 $66,590,987 +$64,204,814 $1.73 56
2026 Q1 343,956 $2,342,341 +$2,342,341 $6.82 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .